SYSTEMATIC REVIEW article
Front. Genet.
Sec. Molecular Cytogenetics
Volume 16 - 2025 | doi: 10.3389/fgene.2025.1502538
Exome Sequencing and Prenatal Skeletal Abnormalities: Comprehensive Review and Meta-Analysis and Way forward
Provisionally accepted
- 1Suqian First People's Hospital, Suqian, Jiangsu Province, China
- 2Changzhou Maternal and Child Health Care Hospital, Changzhou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objective: To assess the detection rate of exome sequencing (ES) in fetuses diagnosed as skeletal abnormalities (SKA) with normal karyotype or chromosomal microarray analysis (CMA) results.Methods: We conducted electronic searches in four databases, focusing on studies involving ES in fetuses with SKA. Additional detection rate of ES compared to karyotype/CMA was calculated, followed by a meta-analysis. Subgroup analyses explored the influence of fetal phenotype on diagnostic outcomes.Results: From 2393 studies, 21 reports covering 476 fetuses were analyzed. Key findings include: (1) an additional detection rate of ES of 63.2% (Risk Difference(RD), 0.68 [95% CI, 0.60–0.76], p<0.00001); (2) identification of 76 genes across 304 types of variants, with FGFR3, COL1A1, COL1A2, and COL2A1 being prevalent; (3) lower detection rates in fetuses with isolated short long bones compared to non-isolated conditions, though not significantly different (p=0.35); (4) higher detection rates in subgroups with abnormal ossification, small chest, suspected long bone fractures or angulations, and skull abnormalities.Conclusion: The meta-analysis indicates that genetic variation significantly contributes to fetal SKA, primarily due to single-gene variants. Consequently, ES should be used in the prenatal diagnosis of SKA fetuses in clinical practice.
Keywords: exome sequencing, Skeletal abnormalities, Prenatal Diagnosis, Karyotyping, Chromosomal microarray analysis
Received: 27 Sep 2024; Accepted: 14 May 2025.
Copyright: © 2025 Jiang, Zhang, JING, Wei, Mao and Yu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Bin Yu, Changzhou Maternal and Child Health Care Hospital, Changzhou, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.